These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 17344361

  • 1. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica.
    Safaeian M, Herrero R, Hildesheim A, Quint W, Freer E, Van Doorn LJ, Porras C, Silva S, González P, Bratti MC, Rodriguez AC, Castle P, Costa Rican Vaccine Trial Group.
    J Clin Microbiol; 2007 May; 45(5):1447-54. PubMed ID: 17344361
    [Abstract] [Full Text] [Related]

  • 2. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
    Castle PE, Schiffman M, Burk RD, Wacholder S, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
    [Abstract] [Full Text] [Related]

  • 3. Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.
    Dong L, Feng RM, Zhang L, Xu XQ, Zhao XL, Wang MZ, Qiao YL, Zhao FH.
    J Gynecol Oncol; 2017 Sep; 28(5):e66. PubMed ID: 28657227
    [Abstract] [Full Text] [Related]

  • 4. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
    Barzon L, Militello V, Pagni S, Palù G.
    J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
    [Abstract] [Full Text] [Related]

  • 5. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
    Ngou J, Gilham C, Omar T, Goumbri-Lompo O, Doutre S, Michelow P, Kelly H, Didelot MN, Chikandiwa A, Sawadogo B, Delany-Moretlwe S, Meda N, Costes V, Mayaud P, Segondy M.
    J Acquir Immune Defic Syndr; 2015 Feb 01; 68(2):162-8. PubMed ID: 25394189
    [Abstract] [Full Text] [Related]

  • 6. Comparison of two PCR-based human papillomavirus genotyping methods.
    Castle PE, Porras C, Quint WG, Rodriguez AC, Schiffman M, Gravitt PE, González P, Katki HA, Silva S, Freer E, Van Doorn LJ, Jiménez S, Herrero R, Hildesheim A, CVT Group.
    J Clin Microbiol; 2008 Oct 01; 46(10):3437-45. PubMed ID: 18716224
    [Abstract] [Full Text] [Related]

  • 7. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Wang SS, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M, Costa Rica HPV Vaccine Trial (CVT) Group.
    Sex Transm Dis; 2010 Nov 01; 37(11):706-14. PubMed ID: 20661178
    [Abstract] [Full Text] [Related]

  • 8. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H, Rangwala S, Gay T, Keating K, McLeod S, Nazarenko I, O'Neil D, Pfister D, Loeffert D.
    J Clin Virol; 2009 Jul 01; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting.
    Venturoli S, Leo E, Nocera M, Barbieri D, Cricca M, Costa S, Santini D, Zerbini M.
    J Clin Virol; 2012 Feb 01; 53(2):121-4. PubMed ID: 22115872
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
    Park S, Kang Y, Kim DG, Kim EC, Park SS, Seong MW.
    Diagn Microbiol Infect Dis; 2013 Aug 01; 76(4):432-6. PubMed ID: 23791386
    [Abstract] [Full Text] [Related]

  • 11. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE, Reid J, Dockter J, Getman D.
    J Clin Virol; 2015 Aug 01; 69():52-5. PubMed ID: 26209379
    [Abstract] [Full Text] [Related]

  • 12. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Brotherton JML, Tabrizi SN, Phillips S, Pyman J, Cornall AM, Lambie N, Anderson L, Cummings M, Payton D, Scurry JP, Newman M, Sharma R, Saville M, Garland SM.
    Int J Cancer; 2017 Oct 15; 141(8):1576-1584. PubMed ID: 28677147
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials.
    Tota JE, Struyf F, Sampson JN, Gonzalez P, Ryser M, Herrero R, Schussler J, Karkada N, Rodriguez AC, Folschweiller N, Porras C, Schiffman M, Schiller JT, Quint W, Kreimer AR, Wheeler CM, Hildesheim A, Costa Rica Vaccine Trial and PATRICIA Study.
    J Natl Cancer Inst; 2020 Aug 01; 112(8):818-828. PubMed ID: 31697384
    [Abstract] [Full Text] [Related]

  • 14. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [Abstract] [Full Text] [Related]

  • 15. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
    Geraets D, Alemany L, Guimera N, de Sanjose S, de Koning M, Molijn A, Jenkins D, Bosch X, Quint W, RIS HPV TT Study Group.
    J Pathol; 2012 Dec 20; 228(4):534-43. PubMed ID: 22711526
    [Abstract] [Full Text] [Related]

  • 16. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
    Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M.
    J Clin Microbiol; 2008 Jan 20; 46(1):109-17. PubMed ID: 17989194
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus genotype specificity of hybrid capture 2.
    Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M.
    J Clin Microbiol; 2008 Aug 20; 46(8):2595-604. PubMed ID: 18579716
    [Abstract] [Full Text] [Related]

  • 18. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Intaraphet S, Siriaunkgul S.
    J Med Virol; 2016 Jan 20; 88(1):135-43. PubMed ID: 26129775
    [Abstract] [Full Text] [Related]

  • 19. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.
    van Doorn LJ, Molijn A, Kleter B, Quint W, Colau B.
    J Clin Microbiol; 2006 Sep 20; 44(9):3292-8. PubMed ID: 16954263
    [Abstract] [Full Text] [Related]

  • 20. Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework.
    Xu L, Padalko E, Oštrbenk A, Poljak M, Arbyn M.
    Int J Mol Sci; 2018 Sep 11; 19(9):. PubMed ID: 30208597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.